Brendel Financial Advisors LLC Vertex Pharmaceuticals Inc Transaction History

Brendel Financial Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 12, 2023	BUY	$338.18 - $362.46 $80,825 - $86,627	239 Added 4.61%	5,423 $1.89 Million
Q2 2023 Jul 21, 2023	SELL	$314.42 - $351.91 $238,959 - $267,451	-760 Reduced 12.79%	5,184 $1.82 Million
Q1 2023 Apr 06, 2023	BUY	$283.23 - $323.1 $86,951 - $99,191	307 Added 5.45%	5,944 $1.87 Million
Q4 2022 Jan 20, 2023	BUY	$285.76 - $321.48 $1.61 Million - $1.81 Million	5,637 New	5,637 $1.63 Million

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Brendel Financial Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Brendel Financial Advisors LLC with notifications on news.